TARGETED DELIVERY OF siRNA TO CELL DEATH PROTEINS IN SEPSIS-Reference-Cited by-同舟云学术

TARGETED DELIVERY OF siRNA TO CELL DEATH PROTEINS IN SEPSIS

Published:2009-08 Issue:2 Volume:32 Page:131-139
ISSN:1073-2322
Container-title:Shock
language:en
Short-container-title:

Author:

Brahmamdam Pavan,Watanabe Eizo,Unsinger Jacqueline,Chang Katherine C.,Schierding William,Hoekzema Andrew S.,Zhou Tony T.,McDonough Jacquelyn S.,Holemon Heather,Heidel Jeremy D.,Coopersmith Craig M.,McDunn Jonathan E.,Hotchkiss Richard S.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Critical Care and Intensive Care Medicine,Emergency Medicine

Reference44 articles.

1. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.;Angus;Crit Care Med,2001

2. Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment.;Zeni;Crit Care Med,1997

3. The pathophysiology and treatment of sepsis.;Hotchkiss;N Engl J Med,2003

4. Delayed hypersensitivity: indicator of acquired failure of host defenses in sepsis and trauma.;Meakins;Ann Surg,1977

5. The effects of injury on the adaptive immune response.;Lederer;Shock,1999

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The state-of-the-art therapeutic paradigms against sepsis;Smart Materials in Medicine;2024-09

2. Cell death proteins in sepsis: key players and modern therapeutic approaches;Frontiers in Immunology;2024-01-11

3. Inflammation-responsive drug delivery nanosystems for treatment of bacterial-induced sepsis;International Journal of Pharmaceutics;2023-09

4. Non-viral siRNA delivery to T cells: Challenges and opportunities in cancer immunotherapy;Biomaterials;2022-07

5. Delivery strategies of RNA therapeutics to leukocytes;Journal of Controlled Release;2022-02